Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

A Novel Model of Asymptomatic Plasmodium Parasitemia That Recapitulates Elements of the Human Immune Response to Chronic Infection.

Fontana MF, Baccarella A, Craft JF, Boyle MJ, McIntyre TI, Wood MD, Thorn KS, Anidi C, Bayat A, Chung MR, Hamburger R, Kim CY, Pearman E, Pham J, Tang JJ, Boon L, Kamya MR, Dorsey G, Feeney ME, Kim CC.

PLoS One. 2016 Sep 1;11(9):e0162132. doi: 10.1371/journal.pone.0162132. eCollection 2016.

2.

DNA-Containing Immunocomplexes Promote Inflammasome Assembly and Release of Pyrogenic Cytokines by CD14+ CD16+ CD64high CD32low Inflammatory Monocytes from Malaria Patients.

Hirako IC, Gallego-Marin C, Ataide MA, Andrade WA, Gravina H, Rocha BC, de Oliveira RB, Pereira DB, Vinetz J, Diamond B, Ram S, Golenbock DT, Gazzinelli RT.

MBio. 2015 Nov 17;6(6):e01605-15. doi: 10.1128/mBio.01605-15.

3.

Poor memory B cell generation contributes to non-protective responses to DTaP vaccine antigens in otitis-prone children.

Basha S, Pichichero ME.

Clin Exp Immunol. 2015 Dec;182(3):314-22. doi: 10.1111/cei.12660. Epub 2015 Sep 30.

4.

Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function.

Portugal S, Tipton CM, Sohn H, Kone Y, Wang J, Li S, Skinner J, Virtaneva K, Sturdevant DE, Porcella SF, Doumbo OK, Doumbo S, Kayentao K, Ongoiba A, Traore B, Sanz I, Pierce SK, Crompton PD.

Elife. 2015 May 8;4. doi: 10.7554/eLife.07218.

5.

Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.

Hodgson SH, Choudhary P, Elias SC, Milne KH, Rampling TW, Biswas S, Poulton ID, Miura K, Douglas AD, Alanine DG, Illingworth JJ, de Cassan SC, Zhu D, Nicosia A, Long CA, Moyle S, Berrie E, Lawrie AM, Wu Y, Ellis RD, Hill AV, Draper SJ.

Mol Ther. 2014 Dec;22(12):2142-54. doi: 10.1038/mt.2014.157. Epub 2014 Aug 26.

6.

Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer.

Scheiermann J, Klinman DM.

Vaccine. 2014 Nov 12;32(48):6377-89. doi: 10.1016/j.vaccine.2014.06.065. Epub 2014 Jun 24. Review.

7.

Microbial TLR Agonists and Humoral Immunopathogenesis in HIV Disease.

Yu X, Li Z, Zhou Z, Kilby JM, Jiang W.

Epidemiology (Sunnyvale). 2013 Feb 2;3:120.

8.

Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.

Crompton PD, Moebius J, Portugal S, Waisberg M, Hart G, Garver LS, Miller LH, Barillas-Mury C, Pierce SK.

Annu Rev Immunol. 2014;32:157-87. doi: 10.1146/annurev-immunol-032713-120220. Review.

9.

Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.

Elias SC, Choudhary P, de Cassan SC, Biswas S, Collins KA, Halstead FD, Bliss CM, Ewer KJ, Hodgson SH, Duncan CJ, Hill AV, Draper SJ.

Immunology. 2014 Apr;141(4):628-44. doi: 10.1111/imm.12226.

10.

Chemical cross-linking of HIV-1 Env for direct TLR7/8 ligand conjugation compromises recognition of conserved antigenic determinants.

Feng Y, Forsell MN, Flynn B, Adams W, Loré K, Seder R, Wyatt RT, Karlsson Hedestam GB.

Virology. 2013 Nov;446(1-2):56-65. doi: 10.1016/j.virol.2013.07.028. Epub 2013 Aug 15.

11.

Long-lived Plasmodium falciparum specific memory B cells in naturally exposed Swedish travelers.

Ndungu FM, Lundblom K, Rono J, Illingworth J, Eriksson S, Färnert A.

Eur J Immunol. 2013 Nov;43(11):2919-29. doi: 10.1002/eji.201343630. Epub 2013 Aug 29.

12.

Young lives lost as B cells falter: what we are learning about antibody responses in malaria.

Portugal S, Pierce SK, Crompton PD.

J Immunol. 2013 Apr 1;190(7):3039-46. doi: 10.4049/jimmunol.1203067. Review.

13.

Adjuvants for Leishmania vaccines: from models to clinical application.

Raman VS, Duthie MS, Fox CB, Matlashewski G, Reed SG.

Front Immunol. 2012 Jun 11;3:144. doi: 10.3389/fimmu.2012.00144. eCollection 2012.

14.

Antigen-specific B memory cell responses to Plasmodium falciparum malaria antigens and Schistosoma haematobium antigens in co-infected Malian children.

Lyke KE, Wang A, Dabo A, Arama C, Daou M, Diarra I, Plowe CV, Doumbo OK, Sztein MB.

PLoS One. 2012;7(6):e37868. doi: 10.1371/journal.pone.0037868. Epub 2012 Jun 5.

15.

Cytosine-phosphate-guanosine-DNA induces CD274 expression in human B cells and suppresses T helper type 2 cytokine production in pollen antigen-stimulated CD4-positive cells.

Kubo S, Yamada T, Osawa Y, Ito Y, Narita N, Fujieda S.

Clin Exp Immunol. 2012 Jul;169(1):1-9. doi: 10.1111/j.1365-2249.2012.04585.x.

16.

Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children.

Ndungu FM, Olotu A, Mwacharo J, Nyonda M, Apfeld J, Mramba LK, Fegan GW, Bejon P, Marsh K.

Proc Natl Acad Sci U S A. 2012 May 22;109(21):8247-52. doi: 10.1073/pnas.1200472109. Epub 2012 May 7.

17.

Intrinsic differences in the initiation of B cell receptor signaling favor responses of human IgG(+) memory B cells over IgM(+) naive B cells.

Davey AM, Pierce SK.

J Immunol. 2012 Apr 1;188(7):3332-41. doi: 10.4049/jimmunol.1102322. Epub 2012 Feb 29.

18.

Plasmodium falciparum malaria in the Peruvian Amazon, a region of low transmission, is associated with immunologic memory.

Clark EH, Silva CJ, Weiss GE, Li S, Padilla C, Crompton PD, Hernandez JN, Branch OH.

Infect Immun. 2012 Apr;80(4):1583-92. doi: 10.1128/IAI.05961-11. Epub 2012 Jan 17.

19.

A review of malaria vaccine clinical projects based on the WHO rainbow table.

Schwartz L, Brown GV, Genton B, Moorthy VS.

Malar J. 2012 Jan 9;11:11. doi: 10.1186/1475-2875-11-11. Review.

20.

Kinetics of humoral and memory B cell response induced by the Plasmodium falciparum 19-kilodalton merozoite surface protein 1 in mice.

Kafuye-Mlwilo MY, Mukherjee P, Chauhan VS.

Infect Immun. 2012 Feb;80(2):633-42. doi: 10.1128/IAI.05188-11. Epub 2011 Nov 21.

Supplemental Content

Support Center